Patent details
EP1648465 Title: USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH PLATINUM COMPOUNDS AND OPTIONALLY IONISING RADIATION IN THE TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS AND/OR INCREASED VASCULAR PERMEABILITY
Basic Information
- Publication number:
- EP1648465
- PCT Application Number:
- PCT/GB/2004/002932
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP047432752
- PCT Publication Number:
- WO/2005/004870
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH PLATINUM COMPOUNDS AND OPTIONALLY IONISING RADIATION IN THE TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS AND/OR INCREASED VASCULAR PERMEABILITY
- French Title of Invention:
- UTILISATION DU DERIVE QUINAZOLINE ZD6474 EN COMBINAISON AVEC DES COMPOSES DE PLATINE ET EVENTUELLEMENT DE RAYONNEMENT IONISANT DANS LE TRAITEMENT DES MALADIES ASSOCIEES A L'ANGIOGENESE ET/OU A UNE PERMEABILITE VASCULAIRE ACCRUE
- German Title of Invention:
- VERWENDUNG DES CHINAZOLIN-DERIVATS ZD6474 IN KOMBINATION MIT PLATINVERBINDUNGEN UND OPTIONAL IONISIERENDER STRAHLUNG BEI DER BEHANDLUNG VON ERKRANKUNGEN IM ZUSAMMENHANG MIT ANGIOGENESE UND/ODER ERHÖHTER GEFÄSSPERMEABILITÄT
- SPC Number:
Dates
- Filing date:
- 07/07/2004
- Grant date:
- 25/08/2010
- EP Publication Date:
- 25/08/2010
- PCT Publication Date:
- 20/01/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/04/2006
- EP B1 Publication Date:
- 25/08/2010
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 07/07/2014
- Expiration date:
- 07/07/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/07/2004
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Agent
- Name:
- OFFICE DE BREVETS MEYERS & VAN MALDEREN
- From:
- 31/05/2011
- Address:
- PO Box 111, 8002, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- RYAN Anderson Joseph, AstraZeneca R & D Alderley
- Address:
- United Kingdom (GB)
2
- Name:
- WEDGE Stephen Robert, AstraZeneca R & D Alderley
- Address:
- United Kingdom (GB)
Priority
1
- Priority Number:
- 0316176
- Priority Date:
- 10/07/2003
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 0406546
- Priority Date:
- 24/03/2004
- Priority Country:
- United Kingdom (GB)
3
- Priority Number:
- 0407753
- Priority Date:
- 06/04/2004
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 31/517;
| Filing date | Document type | Number of pages |
|---|